CTOs on the Move


 
As the intraoperative imaging expert, IMRIS, Deerfield Imaging measurably improves patient outcomes through planning, product integration and clinical workflow to give surgeons access to diagnostic quality scans in operating room suites. The IMRIS Surgical Theatre, which uniquely transport MR and CT scanners to the patient using ceiling-mounted rails and incorporate other IMRIS imaging technology, are sold globally to hospitals that deliver clinical services to patients in neurosurgical, spinal, interventional and orthopedic markets.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.imris.com
  • 5101 Shady Oak Rd
    Minnetonka, MN USA 55343
  • Phone: 763.203.6300

Executives

Name Title Contact Details

Similar Companies

Pocono Medical Care Inc

Pocono Medical Care Inc is a Milford, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Planmeca USA

Planmeca USA, a leading manufacturer of dental imaging and CAD/CAM equipment, recently moved its North American headquarters to a larger, high-tech facility that will house advanced training and facilitate innovation.

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.

Tearlab

TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.

The Sapling Co.

The Sapling Co. is a Huntingdon Valley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.